La Superintendencia Nacional de Aduanas y de Administración Tributaria

desferrioxamine in thalassaemic patients. Drug Metabolism and Disposal, 21 ;4: 640-644.

LEECH. D. (1994). Affinity biosensors. Chemical Society Reviews, 23: 205'2^3. LECHUGA. LM .. LENFERINK. A.T.M.. KOOYMAN. R.P.H. and GREVE. J. (1995). Feasability of optical waveguide immunosensors for pesticide detection: chemical aspects Sensors and Actuators B, 24-25: 762-765.

L’EPLATTENIER, R, MURASE, I. and MARTELL, A.E. (1967). New multidentate ligands. VI. Chelating tendencies of N,N',-bis [2-hydroxybenzyl]-ethylene diamine- N,N’,-diacetic acid. Journal of the American Chemical Society, 89: 837-843.

LEROY, D., EXPERT, D., RAZAFINDRATSITA, A., DEROUSSENT, A., GOSME, J., BOHUON, 0. and ANDREMONT, A. (1992). Activity and specificity of a mouse monoclonal antibody to ferric aerobactin. Infection and Immunity, 60; 3: 768-772. LERNER, R.A., KANG, A.S., BAIN, J.D., BURTON, D.R. and BARBAS III, C.R (1992). Antibodies without immunisation. Sc/ence, 258: 13131314.

LIM, C.J., HALLER, B. and FUCHS, J.A. (1985). Thioredoxin is the bacterial protein encoded by tip that is required for filamentous bacteriophage fl assembly. Journal of Bacteriology, 161: 799-802.

LOLOV, S., TYUTYULKOVA, S., MARINOVA, I., KEHAYOV, I. and KYUKCHIEV, S. (1993). Conformation-sensitive immunoassay: optimisation, validation and evaluation. Journal of Immunological Methods, 157: 19-23.

LOW, N.M., HOLLIGER, P., and WINTER, G. (1996). Mimicking somatic hypermutation: Affinity maturation of antibodies displayed on bacteriphage using a bacterial mutator strain. Journal of Molecular Biology, 260: 359-368.

LOWTHER, N., HASSAN, I.F. and MATTHEWS, I.T.W. (1993). Desferrioxamine-B salts and their use as orally effective iron chelators. Patent Ciba-Geigy AG, WO- 9324451 .A.

LOYEVSKY, M., LYTTON, S.D., MESTER, B, LIBMAN, J., SHANZER, and CABANTCHIK, Z.I. (1993). The antimalarial action of desferal involves a direct access route to erythrocyte (Plasmodium falciparum) parasites. Journal of Clinical Investigation, 91; 1: 218-224.

LU, Z., MURRAY, K.S., VAN CLEAVE, V., LaVALLIE, E.R., STAHL, M.L. and McCOY, J.M. (1995). Expression of thioredoxin random peptide libraries on the Eschericia co//cell surface as functional fusions to flagellin: A system designed for exploring protein-protein interactions. Bio/Technology, 13: 366-372.

MAEDA, M. (1995). The assay of enzyme activity in EIA- colorimetric, fluorometric and luminometric method. Nippon Rinsho, 53; 9: 2198-2202.

MacCALLUM, R.M., MARTIN, A.C. and THORNTON, J.M. (1996). Antibody-antigen interactions: contact analysis and binding site topography. Journal of Molecular Biology, 262; 5: 732-745.

MALCOM, S., BARTON, P., MURPHY, C., FERGUSON-SMITH, M.A., BENTLEY, D.L. and RABBITS, T.H. (1982). Localisation of human immunoglobulin kappa light chain variable region genes to the short arm of chromosome

2

MALMBORG, A.C and and BORREBAECK, C.A. (1995). BIAcore as a tool in antibody engineering. Journal of Immunological Methods, 183; 1: 7-13.

MALMBORG, A.C., DUENAS, M., OHLIN, M., SÔDERLIND, E., and BORREBAECK, C.A.K. (1996). Selection of binders from phage displayed antibody libraries using the BIAcoreT^"^ biosensor. Journal of Immunological Methods, 198;

1

M c C o n n e ll, S.J., UVEGES, A.J., FOWLKES, D.M. and SPINELLA, D.G. (1995). Construction and screening of M l3 phage libraries displaying random peptides. Molecular Diversity, 1 ; 3: 165-176.

MARCIANI. M.G., CIANCIULLI, P., STEFANI, N., STEFANINI, F., SABBADINI, L.P.M., MASCHIO, M., TRUA, G. and PAPA, G. (1991). Toxic effects of high-dose deferoxamine treatment in patients with iron overload: An electrophysiological study of cerebral and visual function. Haematologica, 76:131-134.

MARCIANI M, G., STEFANI, N., STEFANINI, F., MASCHIO, M.C.E., SPANEDDA, F., GIGLI, G.L., PAPA, G. and CIANCIULLI, P. (1993). Visual function during long-term desferrioxamine treatment. The Lancet, 341: 491.

MARCO, M.P., GEE, S. and HAMMOCK, B.D. (1995). Immunochemical techniques for enviromental anaylsis I. Immunosensors. Trends In Analytical Chemistry, 14:

MARKS, J.D., HOOGENBOOM, H.R., BONNERT, T.P., McCAFFERTY, J., GRIFFITHS, A.D. and WINTER, G. (1991). By-passing immunisation: Human antibodies from v-gene libraries displayed on phgage. Journal of Molecluar Biology,

222

MAROUN, C.R. and JULIUS, M. (1994). Distinct involvement of CD45 in antigen receptor signalling in CD4+ and CD

8

MARTIN, A.C.R., CHEETHAM, J.G. and REES, A.R. (1989). Modeling antibody hypervariable loops: A combined algorithm. Proceedings of the National Acadamy of Sciences of the United States of America,

86

De MASSY, B., WEISBURG, R.A. and STUDIER, F.W. (1987). Gene 3 endonuclease of bacteriophage T7 resolves conformationally branched structures in double-stranded DNA. Journal of Molecular Biology, 193; 2: 359-376.

MATZANKE, B.F., MÜLLER-MATZANKE, G. and RAYMOND, K.N. (1989). Siderophore mediated iron Transport. In Physical Biorganic Chemistry 5, Iron Carriers and Iron Proteins, Loeher, T.M. (Ed) 1:1-121.

MAX, E. (1993). Immunoglobulins. Molecular Genetics. In Fundamental Immunology 3r6 Edition, Paul, W.E. (Ed): 315-382, Raven Press, New York.

McCAFFERTY, J., GRIFFITHS, A.D., WINTER, G. and CHISWELL, D.J. (1990). Phage antibodies:filamentous phage displaying antibody variable domains. Nature, 348: 552-554.

McLACHLAN, D.R.C., DALTON, A.J., KRUCK, T.P.A., BELL, M.Y., SMITH, W.L., KALOW, |W. and ANDREWS, D.F. (1991). Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet, 337: 1304-1308.

M c L a re n , G.D., MUIR, W.A. and KELLERMEYER, R.W. (1983). Iron overload disorders: natural history, pathogenesis, diagnosis and therapy. Critical Reviews in Clinical Laboratory Sciences, 19, 3: 205-266.

MEFFRE, E., FOUGERREAU, M., ARGENSON, J.N., AUBANIAC, J.M. and SCHIFF, C. (1996). Cell surface expression of surrogate light chain (psi L) in the absence of mu on human pro-B cell lines and normal pro-B cells. European Journal of Immunology, 26; 9: 2172-2180.

MEHTA, B.C., PANDYA, B.G., MEHTA, J.B. and BISARIYA, B.N. (1989). Iron loading anaemias. Journal of the Association of Physicians of India, 37: 754-756. MEINDL, A., KLOBECK, H.G., OHNHEISER, R and ZACHAU, H.G. (1990). The V kappa repertoire in the human germ line. European Journal of Immunology, 2 0 ;

8

MELCHERS, F., KARASUYAMA, H., HAASNER, D., BAUER, S., KUDO, A., SAKAGUCHI, N., JAMESON, B. and ROLINK, A. (1993). The surrogate light chain in B-cell development. Immunology Today, 14;2: 60-68.

MENG, J., JOHN, T.R. and KAISER, 1.1. (1995). Specificity and binding affinity of an anti-crotoxin combinatorial antibody selected from a phage-displayed library. Biochemical Pharmacology, 50;12: 1969-1977.

MESSING, J. (1983). New M l 3 vectors for cloning. Methods in Enzymology, 101 : 20-78.

MESSING, J. (1991). Cloning in M l 3 phage or how to use biology at its best. Gene, 100: 3-12.

MESTECKY, J. and McGHEE, J.R. (1987). Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and imune response. Advances in Immunology, 40: 153-245.

MEYER-BRUNOT, H.G. and KEBERLE, H. (1967). The metabolism of desferrioxamine B and ferrioxamine B. Biochemical Pharmacolgy, 16: 527-535. MIKAWA, Y.G., MARUYAMA, I.N. and BRENNER, S. (1996). Surface display of proteins on bacteriophage. Journal of Molecular Biology, 262: 21-30.

MODELL, C.B. and BECK, J. (1974). Long-term desferrioxamine therapy in p- thalassaemia. Annals of the New York Academy of Sciences, 232: 201 -210.

MONZYK, B. and CRUMBLISS, A.L. (1982). Kinetics and mechanism of the stepwise dissociation of Iron (III) from Ferrioxamine B in aqueous acid. Journal of the American Chemical Society, 104: 4921-4929.

MOREL. I., CILLARD, J., LESGOAT, G.. SERGENT. O.. PESDELOUP. N.. OCAKTAN. A.Z.. ABDALLAH. M.A.. BRISSOT. P. and CILLARD. P. (1992). Antioxidant and free radical scavanging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine. Free Radicals in Biological Medicine, 13: 499-508.

MOSIER. D.E. and SUBBARAO. B. (1982). Thymus-independent antigens: complexity of B-lymphocyte activation revealed. Immunology Today, 3;

8

MULLER. G.. MATZANKE. B.F. and RAYMOND. K.N. (1984). Iron transport in Streptomyces pilosus mediated by ferrichrome siderophores. rhodotorulic acid, and enantio-rhodotorulic acid. Journal of Bacteriology, 160: 313-318.

NAKANE. P.K. and PIERCE. G.B. (1966). Enzyme-labeled antibodies: Preparation and application for the localisation of antigens. Journal of Histochemistry and cytochemistry, 14: 929-931.

NAKATA. M. and OHKAWA. H. (1996). Enzyme immunoassay with monoclonal antibody for enviromental contaminants. Tanpakushitsu Kakusan Koso, 41; 14: 2132-2138.

NEILANDS. J.B. (1981). Microbial iron compounds. Annual Reviews in Biochemistry, 50: 715-731.

NEWTON, S.M.C., JACOB, 0 .0 . and STOCKER, B.A.D. (1989). Immune response to choiera toxin epitope inserted in Salmonella flagellin. Science,

2

NISHIHARA, K. (1995). Enzyme immunoassay of drug in blood (serum). Nippon Rinsho, 53 ,9:2 30 1-23 09 .

NISHIJIMA M. (1995). Enzyme immunoassay of pesticide residues in foods. Nippon Rinsho, 53, 9:2310-2315.

NISONOFF, A., HOPPER, J.E. and SPRING, S.B. (1975). The Antibody Molecule’. Academic Press, New York.

NISSIM, A., HOOGENBOOM, H.R., TOMLINSON, I.M., FLYNN, G., MIDGLEY, C., LANE, D. and WINTER, G. (1994). Antibody fragments from a ‘single pot’ phage display library as immunological reagents. The EMBO Journal, 13; 3: 692-698. OLIVIERI, N.F. (1996). Long-term therapy with deferiprone. Acta Heamatoligica, 95; 1: 37-48.

OLIVIERI, N.F., BUNCIC, J.R., CHEW, E., GALLANT, T., HARRISON, R.V., KEENAN, B.A., LOGAN, W., MITCHELL, D., RICCI, G., SKARF, B., TAYLOR, M. and FREEDMAN, M.H. (1993). Visual and auditory neurotoxicity in patients recieving subcutaneous deferoxamine infusions. The New England Journal of Medicine, 314; 14: 869-873.

ONG, S.A., PETERSON, T. and NEILANDS, J.B. (1979). Agrobactin, a siderophore from Agrobacterium tumeracians. Journal of Biological Chemistry, 254: 1860-1865.

OUDIN, J. (1946). Method of immunochemical analysis by specific precipitation in gelled medium. Comptes Rendus Académie des Sciences, Paris, 222: 115-116. PARKER, D.C. (1993). T cell-dependent B cell activation. Annual Review of Immunology, 11: 331-360.

PARMLEY, S.F. and SMITH, G.P. (1988). Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene, 73;

2

PASQUALINI, R. and ROUSLAHTI, E. (1996). Organ targeting in vivo using phage display peptide libraries. Nature, 380; 6572: 364-366.

PAYNE, S.M. (1980). Synthesis and utilisation of siderophores by Shigella flexneri. Journal of Bacteriology, ^^3: 1420-1424.

PENNEY, C .L, GAULDIE, J., EVELEGH, M., PENNEY, M.T., CHONG< D. and HORSEWOOD, P. (1898). Polycarbonate membranes: a novel surface for solid- phase determinations with utility in field format serological assays. Journal of Immunological Methods, 123: 185-192.

PERSSON, B., STENHAG, K., NISSON, P., LARSSON, A., UHLEN, M. and NYGREN, P. (1997). Analysis of oligonucleotide probe affinities using surface plasmon resonance: a means for mutational scanning. Analytical Biochemistry, 246; 1: 34-44.

PETER, H.H. (1975). The present state of iron-chelation therapy. Transcript from Thalassaemia Today meeting: 69-81.

PETER, H.H. (1983). Iron chelation. Biological significance and medical application. Schweizer Medizinische Wochenscherift, 113; 40: 1428-1433.

PETERS, G., KEBERLE, H., SCHMID, K. and BRUNNER, H. (1966). Distribution and renal excretion of desferrioxamine and ferrioxamine in the dog and in the rat. Biochemical Pharmacology, 15: 93-109.

PETERSEN, L.C. and PERSSON, E. (1996). Effect of on the structure of factor Vila. Haemostasis, 2 6 ;1: 40-44.

PETERSON, G.M., GRAZIANO, J.H. GRADY, R.W., JONES, R.L, MARKENSON, A., LAVI, U., CANALE, V., GREY, G.F., CERAMI, A. and MILLER, D.R. (1979). Chelation therapy in p-thalassemia major: a one-year double blind study of 2,3- hydroxybenzoic acid. Experimental Haematology, 7: 74-80.

PETERSON, P.A., CUNNINGHAM, B.A., BERGGARD, I. and EDELMAN, G.M. (1972). pg-microglobulin - a free Ig domain. Proceedings of the National Acadamy of Sciences of the United States of America, 69: 1697-1701.

PETERSON, T., FALK, K.E., LEONG, S.A., KLEIN, M.P. and NEILANDS, J.B. (1980). Structure and behaviour of spermidine siderophores. Journal of the American Chemical Society,

102

PETRENKO, V.A., SMITH, G.P., GONG, X. and QUINN, T. (1996). A library of organic landscapes on filamentous phage. Protein Engineering, 9; 9: 797-801. PIPPARD, M.J., JACKSON, M.J., HOFFMAN, K., PETROU, M. and MODELL, C.B. (1986). Iron chelation using subcutaneous infusions of diethyl triaminepenta-acetic acid (DTPA). Scandinavian Journal of Haematology, 36: 466-472.

POLLACK, J.R. and NEILANDS, J.B. (1970). Enterobactin, an iron transport compound from Salmonella typhimurium. Biochemical and Biophysical Research Communications, 38: 989-992.

PONKA, P., GRADY, W.R., WILCZYNSKA, A. and SCHULMAN, H.M. (1984). The effect of various chelating agents on the mobilization of iron from reticulocytes in the presence and absence of pyridoxal isonicotinoyl hydrazone. Biochemica et Biophysica Acta, 802: 477-489.

PORTER, J.B. (1996). Bacterial infections in thalassaemia. Thalassaemia International Federation News, 17: 13.

PORTER, J.B., ABEYSINGHE, R.D., MARSHALL, L , HIDER, R.C. and SINGH, S. (1996). Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy. Blood,

88

PORTER, J.B., HUEHNS, E.R. and HIDER, R.C. (1989). The development of iron chelating drugs Bail here’s Clinical Haematology, 2; 2: 257-292.

POTTER, K.N., LI, Y. and CAPRA, J.D. (1996). Staphylococcal protein A simultaneously interacts with framework region

1

PROPPER, R.D. and NATHAN, D.G. (1982). Clinical removal of iron. Annual Reviews in Medicine, 33: 509-519.

PROPPER, R.D., SHURIN, S. and NATHAN, D.G. (1976). Reassessment of the use of desferrioxamine B in iron overload. New England Journal of Medicine, 294: 1421-1423.

PROPPER, R.D., COOPER, B., RUFO, R.R., NIENHUIS, A.W., ANDERSON, W.F., BUNN, H.F., ROSENTHAL, A. and NATHAN, D.G. (1977). Continuous subcutaneous administration of desferrioxamine in patients with iron overload. New England Journal of Medicine, 297: 418-423.

RABBANY, S.Y., DONNER, B.L. and LIGLER, F.S. (1994). Optical immunosensors. Critical Reviews in Biomedical Engineering,

22

RAO, L.V., WILLIAMS, T. and RAPAPORT, S.l. (1996). Studies of the activation of factor VII bound to tissue factor. Blood, 87; 9: 3738-3748.

RAPAPORT, S.l. (1991). The regulation of blood coagulation in normal hemostasis. In Proceedings of 2nd Symposium on New Aspects of Hemophilia

Treatment Hedner, U. and Roberts, H.R. (Eds), 5-14, Medicom Europe, Bussum, NL.

RAVENTOS-SAUREZ, C., POLLACK, S. and NAGEL, R.L (1984). Plasmodium falciparum: inhibition of in vitro growth by desferrioxamine. American Journal of Tropical Medicine and Hygiene, 31: 919-922.

REN, Z.J., LEWIS, O.K., WINGFEILD, E.G., LOCKE, E.G., STEVEN, A.C. and BLACK, LW . (1996). Phage display of intact domains at high copy number: A system based on SOC, the small outer capsid protein of bacteriophage 14. Protein Science, 5: 1833-1843.

RETH, M. (1994). B cell antigen receptors. Current Opinion in Immunology,

6

RESTA, R. and THOMPSON, L.F. (1997). T cell signalling through CD73. Cellular Signalling, 9; 2: 131-139.

RICE-EVANS, C., BAYSAL, E., SINGH, S., JONES, S.A. and JONES, J.G. (1989). The interactions of desferrioxamine and hydroxypyridone compounds with haemoglobin and erythrocytes. FEBS Letters, 256; 1-2: 17-20.

RICHARDSON, D.R., TRAN, E.H. and PONKA, P. (1995). The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents. Blood,

86

RISSE, M. and WEILER, G. (1987). Hemosiderin findings in the liver, spleen and lung in newborn infants and infants. Z.Rechtsmedizin, 98: 181-190.

ROBINS-BROWNE, R.M. and PRPIC, J.K. (1985). Effects of iron and desferrioxamine on infections with Yersinia enterocolitica. Infection and Immunity, 47: 774-779.

ROGGO, B.E. and PETER, H.H. (1993). Synthesis of the metabolite N-hydroxy- desferrioxamine B. Journal of Antibiotics (Tokyo), 46; 2: 294-299.

ROSEBROUGH, S.F. (1993). Plasma stability and pharmacokinetics of radiolabelled deferoxamine-biotin derivatives. The Journal of Pharmacology and